Pronounced dys-autonomic symptoms announcing a primary Sjögren’s syndrome
Submitted: 24 July 2019
Accepted: 20 May 2020
Published: 23 July 2020
Accepted: 20 May 2020
Abstract Views: 1024
PDF: 633
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- C. Caranfil, G. Lorenzon, B. Barberio, R. Ramonda, E.V. Savarino, F. Zingone, Inflammatory bowel diseases and spondyloarthritis: a focus on female patients , Reumatismo: Vol. 76 No. 3 (2024)
- M. Amatruda, N.S. Carucci, C. Fede, G. Conti, Subclinical TRAPS treated with canakinumab , Reumatismo: Vol. 73 No. 2 (2021)
- C. Palazzi, I. Olivieri, C. Salvarani, E. D'Amico, G. Alleva, P. Vitullo, A. Petricca, Reactive arthritis: advances in diagnosis and treatment , Reumatismo: Vol. 54 No. 2 (2002)
- C.A. Scirè, R. Caporali, C. Perotti, C. Montecucco, Plasma procalcitonin in rheumatic diseases , Reumatismo: Vol. 55 No. 2 (2003)
- M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso, Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy , Reumatismo: Vol. 74 No. 3 (2022)
- E. Di Poi, M. Bombardieri, R. Damato, E. Gremese, G. Valesini, GF. Ferraccioli, Neurological involvement in systemic sclerosis. Evidence of a central Raynaud’s phenomenon , Reumatismo: Vol. 53 No. 4 (2001)
- N. Sanghavi, B. Ayesha, Anti-N-methyl-d-aspartate receptor encephalitis: mimicker of lupus and multiple sclerosis , Reumatismo: Vol. 75 No. 4 (2023)
- G. Fiori, L. Amanzi, A. Moggi Pignone, F. Braschi, M. Matucci- Cerinic, The treatment of skin ulcers in patients with systemic sclerosis , Reumatismo: Vol. 56 No. 4 (2004)
- M. Filippini, G. Fontana, P. Bizioli, F. Crisafulli, R. Orabona, S. Zatti, F. Franceschini, A. Tincani, Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes , Reumatismo: Vol. 76 No. 3 (2024)
- G. Adami, S. Zanon, A. Fassio, G. Pesarini, M. Pighi, R. Scarsini, D. Tavella, M. Rossini, D. Gatti, F. Ribichini, Diffuse idiopathic skeletal hyperostosis is associated with greater complexity of coronary artery disease burden on coronary angiography , Reumatismo: Early Access
<< < 21 22 23 24 25 26 27 28 29 30 > >>
You may also start an advanced similarity search for this article.